Spetzler David Baxley
President
Spetzler David Baxley has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Sep 4, 2026.
On the most recent filing, Spetzler David Baxley is listed as President at Caris Life Sciences, Inc. Inside the rolling window, Spetzler David Baxley reported 1 open-market purchase totaling $10K in CAI and 2 open-market sales totaling $14.8M in CAI. The largest disclosed transaction in the window is a sale of 478,000 CAI shares on Sep 3, 2026, worth $11.9M.
Companies traded
Other insiders at CAI
Insider Buying
$10K
reported purchases (SEC code P)
Insider Selling
$14.8M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Spetzler David Baxley made?
Spetzler David Baxley has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does Spetzler David Baxley trade?
Spetzler David Baxley has filed SEC Form 4 disclosures for 1 company, including CAI.
When was Spetzler David Baxley's most recent SEC Form 4 filing?
Spetzler David Baxley's most recent SEC Form 4 filing on Tracefour is dated Sep 4, 2026.
What is Spetzler David Baxley's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Spetzler David Baxley is listed as President.
What is Spetzler David Baxley's total buy and sell value in the current window?
Inside the rolling retention window, Spetzler David Baxley bought $10K and sold $14.8M based on SEC Form 4 filings.
What was Spetzler David Baxley's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 478,000 CAI shares on 2026-09-03, worth $11.9M, per SEC Form 4 filings.